Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Poyurovsky

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
The British Journal of Psychiatry : the Journal of Mental Science|February 2, 2010
Acute antipsychotic-induced akathisia revisitedMichael Poyurovsky
European Neurology|December 3, 2011
Adenosine A2A-receptor antagonism and pathophysiology of Parkinson's disease and drug-induced movement disordersJaime Kulisevsky, Michael Poyurovsky
Drugs|May 10, 2020
Treatment of Antipsychotic-Induced Akathisia: Role of Serotonin 5-HT<sub>2a</sub> Receptor AntagonistsMichael Poyurovsky, Abraham Weizman
Journal of Clinical Psychopharmacology|October 22, 2015
Treatment of Antipsychotic-Related Akathisia Revisited: The Role of Serotonin 2A Receptor AntagonistsMichael Poyurovsky, Abraham Weizman
Clinical Neuropharmacology|April 3, 2021
Quetiapine for Bipolar Depressive Episode in Obsessive-Compulsive Disorder Patients Maintained on Selective Serotonin Reuptake Inhibitor TreatmentMichael Poyurovsky, Abraham Weizman
Journal of Clinical Psychopharmacology|October 10, 2018
Very Low-Dose Mirtazapine (7.5 mg) in Treatment of Acute Antipsychotic-Associated AkathisiaMichael Poyurovsky, Abraham Weizman
CNS Drugs|December 9, 2004
Obsessive-compulsive disorder in schizophrenia: clinical characteristics and treatmentMichael Poyurovsky, Abraham Weizman, Ronit Weizman
Journal of Psychiatric Research|May 26, 2005
Obsessive-compulsive disorder in elderly schizophrenia patientsMichael Poyurovsky, Josef Bergman, Ronit Weizman
Child Psychiatry and Human Development|June 15, 2007
Insight into obsessive-compulsive symptoms and awareness of illness in adolescent schizophrenia patients with and without OCDSarit Faragian, Rena Kurs, Michael Poyurovsky
International Clinical Psychopharmacology|August 14, 2020
Beneficial effect of quetiapine monotherapy in patients with bipolar depression and comorbid obsessive-compulsive disorderMichael Poyurovsky, Leonid Braverman, Abraham Weizman
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
The British Journal of Psychiatry : the Journal of Mental Science|February 2, 2010
Acute antipsychotic-induced akathisia revisitedMichael Poyurovsky
European Neurology|December 3, 2011
Adenosine A2A-receptor antagonism and pathophysiology of Parkinson's disease and drug-induced movement disordersJaime Kulisevsky, Michael Poyurovsky
Drugs|May 10, 2020
Treatment of Antipsychotic-Induced Akathisia: Role of Serotonin 5-HT<sub>2a</sub> Receptor AntagonistsMichael Poyurovsky, Abraham Weizman
Journal of Clinical Psychopharmacology|October 22, 2015
Treatment of Antipsychotic-Related Akathisia Revisited: The Role of Serotonin 2A Receptor AntagonistsMichael Poyurovsky, Abraham Weizman
Clinical Neuropharmacology|April 3, 2021
Quetiapine for Bipolar Depressive Episode in Obsessive-Compulsive Disorder Patients Maintained on Selective Serotonin Reuptake Inhibitor TreatmentMichael Poyurovsky, Abraham Weizman
Journal of Clinical Psychopharmacology|October 10, 2018
Very Low-Dose Mirtazapine (7.5 mg) in Treatment of Acute Antipsychotic-Associated AkathisiaMichael Poyurovsky, Abraham Weizman
CNS Drugs|December 9, 2004
Obsessive-compulsive disorder in schizophrenia: clinical characteristics and treatmentMichael Poyurovsky, Abraham Weizman, Ronit Weizman
Journal of Psychiatric Research|May 26, 2005
Obsessive-compulsive disorder in elderly schizophrenia patientsMichael Poyurovsky, Josef Bergman, Ronit Weizman
Child Psychiatry and Human Development|June 15, 2007
Insight into obsessive-compulsive symptoms and awareness of illness in adolescent schizophrenia patients with and without OCDSarit Faragian, Rena Kurs, Michael Poyurovsky
International Clinical Psychopharmacology|August 14, 2020
Beneficial effect of quetiapine monotherapy in patients with bipolar depression and comorbid obsessive-compulsive disorderMichael Poyurovsky, Leonid Braverman, Abraham Weizman
Pageof 6